dr. sznol on factors to consider when combining vegf tkis/immunotherapy in rcc
Published 5 years ago • 63 plays • Length 1:28Download video MP4
Download video MP3
Similar videos
-
1:05
dr. sznol discusses immunotherapy combinations in rcc
-
1:25
dr. sznol on patient selection for combination therapy in mrcc
-
1:15
dr. sznol discusses advancements in immunotherapy for rcc
-
1:02
dr. sznol on immunotherapy in patients with rcc
-
1:29
dr. sznol on unanswered questions with immunotherapy in rcc
-
0:50
dr. sznol discusses immunotherapy in non-clear cell renal cancer
-
9:52
factors in selecting immunotherapy or tki inhibition
-
4:27
vegf-tki therapy in first-line mrcc
-
2:31
dr. niu on combining immunotherapy with vegf inhibitors in es-sclc
-
1:22
dr. sznol discusses the combination of ipilimumab and nivolumab in melanoma
-
1:00
dr. sznol on immune-related toxicities in melanoma
-
48:04
introduction & keynote - harnessing the immune system to treat cancer | presented by dr. mario sznol
-
39:34
immunotherapy in renal cell carcinoma
-
1:17
dr. sznol on immunotherapy combinations for the treatment of melanoma
-
8:43
immunotherapy in renal cell carcinoma
-
0:56
dr. sznol on the use of immunotherapy in melanoma
-
2:09
dr. sweis on immunotherapy combinations in kidney cancer
-
4:34
immunotherapy in renal cell carcinoma
-
1:37
mario snozl, m.d. discusses changing outlook for patients with rcc